Nuclear receptors (NRs) repress transcriptional responses to diverse signaling pathways as an essential aspect of their biological activities, but mechanisms determining the specificity and functional consequences of transrepression remain poorly understood. Here, we report signal-and gene-specific repression of transcriptional responses initiated by engagement of toll-like receptors (TLR) 3, 4, and 9 in macrophages. The glucocorticoid receptor (GR) represses a large set of functionally related inflammatory response genes by disrupting p65/interferon regulatory factor (IRF) complexes required for TLR4-or TLR9-dependent, but not TLR3-dependent, transcriptional activation. This mechanism requires signaling through MyD88 and enables the GR to differentially regulate pathogen-specific programs of gene expression. PPAR␥ and LXRs repress overlapping transcriptional targets by p65/IRF3-independent mechanisms and cooperate with the GR to synergistically transrepress distinct subsets of TLR-responsive genes. These findings reveal combinatorial control of homeostasis and immune responses by nuclear receptors and suggest new approaches for treatment of inflammatory diseases.
Introduction

Members
Here, we have used toll-like receptor (TLR) signaling as a model system to explore mechanisms by which different members of the nuclear-receptor superfamily repress proinflammatory programs of gene expression. GR, PPARγ, and LXR agonists were found to repress both common and distinct subsets of TLR target genes through the use of nuclear-receptor-and TLR-specific transrepression mechanisms. Combinations of ago-nists for GR, PPARγ, and LXRs resulted in additive or synergistic inhibition of a subset of TLR4-target genes both in cultured macrophages and in vivo, consistent with the simultaneous targeting of these genes by distinct mechanisms. These findings suggest that nuclear receptors function in a combinatorial manner to coordinately regulate the evolution of host immune responses.
Results
Nuclear Receptors Inhibit Overlapping but Distinct Subsets of LPS-Inducible Genes
Gene-expression profiling experiments were initially performed to identify LPS-inducible genes in primary macrophages that were sensitive to transrepression by the GR agonist dexamethasone (Dex; Figure 1A ). The observation that about half of the LPS-inducible genes were Dex-sensitive raised the questions of how GR discriminated between sensitive and resistant genes and whether these two classes of genes exert distinct biological functions. Recent findings indicate that NCoR corepressor complexes occupy a subset of NF-κB and AP-1 target genes under basal conditions and are cleared in a signal-dependent manner as a prerequisite to transcriptional activation (Ogawa et al., 2004; Perissi et al., 2004 ). Because some NCoR target genes were also subject to Dex-mediated repression, microarray experiments were performed using NCoR −/− macrophages to determine whether NCoR was required for Dex sensitivity (Ogawa et al., 2004 ). Lack of NCoR had no impact on GR-mediated repression ( Figure 1B) , indicating the utilization of NCoR-independent mechanisms. To investigate whether different nuclear receptors repress a common set of LPS target genes, gene expression profiling experiments were performed using nuclear-receptor-specific agonists for PPARγ (rosiglitazone [Ro] and GW7845), LXRα/β (GW3965 and T1317), VDR (1,25-(OH) 2 vitamin D 3 ), ER (17β-estradiol; E 2 ), and RARs (all-trans retinoic acid; atRA). These experiments demonstrated that each agonist exerted an overlapping but distinct impact on LPS-dependent gene expression ( Figures 1C and 1D) . GR, LXR, and PPARγ agonists were the most potent inhibitors of the LPS response, with VDR-, ER-, and RAR-specific agonists exerting relatively modest inhibitory effects under these conditions ( Figure 1C ). Sensitivity to repressive effects of GR, PPARγ, or LXR agonists did not correlate with degree of responsiveness to LPS ( Figure 1C ), absolute expression levels, or a requirement for the p65 component of NF-κB (data not shown and see Figure S1 in the Supplemental Data available with this article online).
p65/IRF3 Complexes Mediate Signal-Specific Inhibition of Transcriptional Responses
Computational motif discovery methods were used to search for potential transcriptional regulatory elements mediating LPS-dependent activation and nuclear-receptor-mediated transrepression. The sequence cAAAct GAAAg was identified as the most highly significant motif enriched in the promoter sequences of LPS target genes (Figure 2A ). This motif is nearly identical to consensus IRF3 and interferon (IFN)-sensitive response element (ISRE) sequences recognized by IRF3 and the type I IFN-inducible ISGF3 complex. Binding of poly I:C to TLR3 and LPS to TLR4, respectively, activates IRF3 and induces ISRE-mediated gene activation (Pitha, 2004; Servant et al., 2002) . We therefore performed expression-profiling experiments to compare the impact of GR, PPARγ, and LXR agonists on transcriptional responses of macrophages to TLR3 and TLR activation ( Figure 2C ). TLR4 signals through both Myd88-dependent and TRIF-dependent pathways, while TLR3 exclusively signals through the TRIF-dependent pathway (Akira and Takeda Figure 2C ; Table S1 ).
As in the case of LPS-dependent gene expression, GR, PPARγ, and LXR agonists repressed both common and nuclear-receptor-specific targets of poly I:C-inducible genes ( Figure 2C ). However, despite the overall similarity in the sets of genes that were transcriptionally activated by LPS and poly I:C, the patterns of GR-, PPARγ-, and LXR-mediated transrepression were significantly different, indicating that nuclear-receptor transrepression is regulated in a signal-specific manner. In particular, a substantial number of genes that were Dex sensitive when activated by LPS became Dex-resistant when activated by poly I:C, illustrated for IP10 and Ifit1 in Figure 2D .
Unexpectedly, nearly all of the highly inducible LPSand poly I:C target genes that were Dex sensitive when activated by LPS but Dex resistant when activated by poly I:C were also highly dependent on IRF3 for LPS induction ( Figure 3A and data not shown). The promoters for many of the genes exhibiting this pattern of expression contained proximal IRF3/ISRE sequences, exemplified by Ifit1 ( Figure 3B ). In contrast, while PPARγ and LXR agonists also inhibited a significant number of IRF3-dependent genes, the signal-specific pattern of sensitivity and resistance differed ( Figures  2C and 3A) . This pattern therefore suggested a mechanistic link between IRF3 and signal-specific transrepression by GR. To test this hypothesis, we evaluated the ability of GR to repress transcriptional activation of an artificial promoter constructed to exclusively contain ISRE elements, which was activated by LPS and poly I:C ( Figure 3C) . Significantly, the induction of the ISREdependent reporter was strongly inhibited by Dex when LPS was used as a stimulus, but not when poly I:C was used as a stimulus ( Figure 3C ment. We therefore characterized the composition of activation complexes bound to the proximal promoter region of Ifit1 in primary macrophages by chromatin immunoprecipitation (ChIP) assay. These experiments demonstrated that IRF3 and CBP were prominently recruited to the ISRE-containing promoter in response to both LPS and poly I:C ( Figure 3E ). In contrast, p65 was specifically recruited to the ISRE in response to LPS, but not in response to poly I:C. Interestingly, the recruitment of p65 to the ISRE in response to LPS was largely inhibited by Dex, but not by PPARγ or LXR agonists ( Figure  3E ). Similar findings were obtained using ChIP to evalu- We therefore evaluated the possibility that GR inhibited LPS induction of the ISRE promoter through direct interactions with p65. In vitro interaction assays confirmed that the GR-DBD strongly interacted with both full-length p65 and further narrowed this interaction to the N-terminal Rel-homology domain (RHD; Figure 4A ). In contrast, the PPARγ-DBD and the LXRα-DBD exhibited minimal interaction with p65 in vitro ( Figure 4A ). These results were confirmed by mammalian twohybrid assays using a Gal4DBD-p65 fusion protein as (Figures 4C and 4D) . Addition of increasing amounts of GR-DBD to the binding reaction led to decreased IRF3 interaction with p65 and a concomitant increase in the binding of the GR-DBD ( Figure 4C ). These findings suggest that GR and IRF3 compete for the same binding site and that GR preferentially interacts with p65.
To determine whether the interaction of GR with p65 was relevant to its repression function, we evaluated a GR mutant in which lysine 471 in the second zinc finger of the DBD was changed to alanine (GR K471A ) based on a previous report that a corresponding mutant is defective for inhibition of p65 activity (Liden et al., 1997) . In contrast to wild-type GR, GR K471A exhibited little interaction with p65 in vitro or in vivo in mammalian twohybrid assays ( Figures 4B and 4E) , and GR K471A lacked inhibitory activity against Gal-p65-mediated transactivation ( Figure 4F ). Consistent with these in vitro findings, wild-type GR was able to inhibit p65-dependent transactivation of a Gal-IRF3 fusion gene, while GR K471A was not ( Figure 4G ), suggesting that direct interaction of GR and p65 is required for GR-mediated transrepression of IRF3. Taken together, these findings support a model in which the requirement of ISRE-containing genes for p65 as a coactivator following LPS activation, but not poly I:C stimulation, accounts for the LPS-specific sensitivity of these genes to transrepression by GR.
IRF3/p65 Complexes Mediate Gene-Specific Inhibition of Transcriptional Responses
In addition to the IRF3 binding motif, κB elements were also highly enriched in promoter regions of LPS-inducible genes (Table S1 ). However, the presence of these sequences did not correlate with signal-or gene-specific patterns of regulation. NF-κB binding sites were identified in promoters of genes that were sensitive to nuclear-receptor agonists following activation by LPS or poly I:C (e.g., iNOS, Figure 2D ), in promoters of genes that were nuclear-receptor-sensitive following LPS but not poly I:C activation (e.g., Clic4, Figure 5A and data not shown), and in promoters of genes that were nuclear receptor resistant regardless of the signal (e.g., Nfkbia and Gro1, Figure 5A and data not shown) . In each case, transcriptional responses to LPS required p65 ( Figure S1 ). The recent finding that a subset of NF-κB sites appear to determine the utilization of IRF3 as a coactivator of p65 (Leung et al., 2004) suggested the possibility that this might be a basis for gene-specific sensitivity to repression by GR. To examine this, we chose the Scyb9 and Clic4 genes because they were highly IRF3 dependent, Dex sensitive NF-κB target genes that did not contain ISRE motifs within their proximal promoter or distal upstream regions ( Figures  5A and 5B ). The Nfkbia and Gro1 genes were chosen for comparison because they were highly induced by LPS in an IRF3-independent manner, were Dex resistant, contained well-characterized κB elements, and lacked proximal or distal ISRE elements ( Figures 5A  and 5B) . ChIP experiments revealed that p65 was recruited to each of these genes in response to LPS, as expected ( Figure 5C ). IRF3 was recruited to the proximal promoter regions of Scyb9 and Clic4 in response to LPS, but not to the Nfkbia or Gro1 promoters, consistent with the requirement of Scyb9 and Clic4 for IRF3 for activation and confirming a gene-specific recruitment of IRF3 to a subset of p65 target genes. Significantly, treatment with Dex had no effect on the recruitment of p65 to any of these four target genes but inhibited the recruitment of IRF3 to the Scyb9 and Clic4 promoters, coincident with ligand-dependent recruitment of GR to these promoters ( Figure 5C ).
MyD88 Dictates GR Sensitivity of IRF3/7-Dependent Gene Expression
Because TLR3 and TLR4 activate IRF3 and NF-κB through the TRIF-dependent pathway, while TLR4, in addition, activates NF-κB and MAP kinases via the MyD88-dependent pathway, these observations raised the possibility that glucocorticoid sensitivity was dictated by the utilization of the MyD88-dependent pathway. To initially test this hypothesis, we determined the profile of dexamethasone-sensitive genes in macrophages treated with immunostimulatory DNA (CpG1668) to activate TLR9, which exclusively couples to the 
et al., 2004). As in the case of polyI:C-stimulated cells, the overall profile of transcriptional activation induced by CpG1668 was very similar to that induced by LPS.
Remarkably, 100% of the genes that were highly induced by all three TLR agonists and were Dex resistant when activated by polyI:C but Dex sensitive when activated by LPS, were also Dex sensitive when activated by CpG1668 ( Figure 3A) . Furthermore, the quantitative extent of Dex-mediated repression was more pronounced following TLR9 stimulation than TLR4 stimulation in nearly every case ( Figure 3A) Figure 5D ). These findings suggest that signaling through the MyD88-dependent pathway specifies Dex sensitivity of this set of genes.
GR, PPAR␥, and LXR Function in a Combinatorial Manner to Inhibit LPS Responses
The observation that GR, PPARγ, and LXR agonists repressed overlapping but distinct sets of LPS target genes by p65-dependent and p65-independent mechanisms raised the possibility that they might exert combinatorial effects on inflammatory responses. To test this hypothesis, gene expression profiling experiments were performed to characterize LPS responses in the presence or absence of combinations of saturating concentrations of GR, PPARγ, and LXR agonists. The results of this analysis for the combination of Dex and the PPARγ agonist GW7845 are illustrated in Figure 6A , restricted to the subset of genes transrepressed by at least one agonist. While several examples were observed in which nuclear-receptor-specific inhibitory effects of one agonist were reversed by addition of the second agonist (red arrows), the major impact of the combination of agonists was to increase the strength of inhibition of a subset of LPS target genes (blue arrows). These results were confirmed by additional experiments that examined the concentration dependence of combinatorial interactions by Northern blot analysis and quantitative PCR analysis of representative target genes ( Figures 6B and 6D ). Low concentrations of Dex and GW7845 (10 nM) that exerted relatively little repressive effects when used individually could act synergistically in combination ( Figure 6B ). Parallel studies of combinations of Dex and GW3965 also demonstrated additive or synergistic effects on LPS target genes (Figure 6C and data not shown) .
To determine whether combinatorial effects of GR, PPARγ, and LXR agonists acted at the promoter level, iNOS promoter activity was evaluated in RAW264.7 cells. The iNOS promoter was chosen for this analysis because the endogenous iNOS gene was subject to combinatorial inhibition by GR, PPARγ, and LXR agonists, its transcriptional activation requires binding sites for NF-κB (Lowenstein et al., 1993) , and maximum responses to LPS required IRF3 (data not shown). As shown in Figure 6E , GR and PPARγ agonists inhibited iNOS promoter activity in a dose-dependent manner. When cells were treated with the combination of Dex and GW7845, at least additive effects with respect to inhibition of LPS response were observed at both saturating and nonsaturating concentrations of ligands (Figure 6E) . Similar results were observed for the combination of GR and LXR agonists (data not shown).
Although GR-mediated repression did not require NCoR ( Figure 1B) , we recently found that the ability of PPARγ to repress LPS activation of the iNOS promoter required NCoR (G.P. and C.K.G., unpublished data). These findings indicate that at least two distinct receptor-specific mechanisms are utilized by GR and PPARγ to repress LPS activation of the iNOS promoter, providing a potential explanation for synergistic repression when GR and PPARγ agonists are used in combination.
To investigate whether combinatorial interactions between PPARγ agonists and Dex observed in primary macrophages would also occur in an in vivo model system, we evaluated the IL-12 p40 subunit, as this was synergistically repressed in primary macrophages by GW7845 and Dex, but not by the combination of Dex and T1317. Consistent with these findings, treatment of mice with the combination of GW7845 and Dex prior to injection with LPS resulted in significantly greater inhibition of circulating IL-12 p40 than either agonist alone ( Figure 6F ). For the combination of GR and LXR agonists, we evaluated TNFα, based on synergistic inhibition by Dex and T1317 in primary macrophages. Treatment of mice with the combination of Dex and T1317 resulted in significantly greater inhibition of circulating tumor necrosis factor α (TNFα) levels following injection with LPS than observed following either agonist alone ( Figure 6G ).
Biological Functions Associated with NuclearReceptor-Sensitive and Nuclear-ReceptorResistant TLR Target Genes
The identification of distinct subsets of TLR3 and TLR4 target genes exhibiting nuclear-receptor-sensitive or nuclear-receptor-resistant profiles raises the question of whether these genes participate in distinct biological processes. Venn diagrams illustrating the overlapping and distinct subsets of genes subject to transrepression by GR, PPAR, and LXR following macrophage activation by LPS and poly I:C are illustrated in Figure 7A . To investigate the potential meaning of these findings at a biological level, statistical analysis of the functional annotations associated with specific sets of differentially regulated genes was performed using annotations provided by the Gene Ontology (GO) database (Gene Ontology Consortium, 2001). A subset of this analysis is presented in Figure 7B , illustrating major categories including immune cell homeostasis, response to virus, cytokine, chemokine signaling, etc. The results of this analysis suggest significant functional differences in the sets of nuclear-receptor-sensitive and nuclear-receptorresistant LPS-target genes. For example, the set of genes that was activated by LPS and resistant to GR, PPARγ, and LXR agonists was enriched for functional annotations linked to metabolism ( Figure 7B) . In addition, transcriptional activation of the core components of the NF-κB pathway by LPS or poly I:C was almost completely resistant to repression by all three nuclearreceptor agonists ( Figure S3B ). We also placed data for GR-mediated repression of LPS-and poly I:C-inducible genes on KEGG pathway maps (Kanehisa, 1996) and provide an example for the TLR signaling pathway in Figure S4 . This figure indicates that components of the TLR signaling pathway in addition to NF-κB factors are Dex resistant, while TLR-activated chemokines and cytokines exhibit differential patterns of sensitivity that relate to proinflammatory effects and chemotaxis.
GR, PPARγ, and LXR regulated functionally overlapping sets of genes, but also targeted genes in functionally related groups in a nuclear-receptor-specific manner. For example, the list of repressed genes with functional annotations linked to hemopoiesis by the Gene Ontology Consortium reached statistical significance for Dex, but not LXR or PPARγ agonists ( Figure  7B ). Repressive actions of each nuclear-receptor ligand on specific genes involved in immune cell migration, differentiation, and activation are illustrated in Figure  S3B . Overall, Dex inhibited a larger number of genes involved in immune cell activation to a greater extent than LXR or PPARγ agonists, which may explain in part why LXR and PPARγ agonists are not as effective as Dex in acute models of inflammation. Significant differences in effects of the three receptor-specific agonists on chemokine gene expression were observed, suggesting that each receptor may play a context-specific role in regulating recruitment of specific immune cells to sites of inflammation.
Discussion
Signal-Specific, Gene-Specific, and NuclearReceptor-Specific Transrepression The present studies have used a combination of gene expression profiling and molecular analysis to investigate nuclear-receptor-specific and combinatorial mechanisms of transrepression by nuclear receptors. These observations extend the spectrum of nuclear-receptor-and promoter-specific inhibition of signal-dependent gene expression, demonstrating that GR, PPARγ, and LXR repress overlapping but distinct subsets of inflammatory response genes, consistent with the large number of mechanisms that have been proposed for negative regulation by nuclear receptors (De Bosscher et al.,  2003) . The observation that a significant set of genes that were sensitive to nuclear-receptor-dependent repression when activated through TLR4 became resistant to repression when activated through TLR3 also indicates that transrepression programs mediated by GR, PPARγ, and LXRs are regulated in a signal-specific manner. Of the 262 genes scored as being LPS inducible and Dex sensitive in these studies, at least 85 genes fit with the hypothesis that disruption of IRF3/ p65 complexes is a quantitatively important component of the transrepression mechanism. Taken together with the results of studies in MyD88 −/− macrophages ( Figure  5D ) and the patterns of gene expression following TLR9 activation ( Figure 3A) , these findings support a unifying model in which TLR signaling through MyD88 specifies glucocorticoid sensitivity of IRF-dependent genes through the utilization of IRF/p65 complexes ( Figure  7C ). As IRF7 is involved in TLR9-MyD88-dependent gene activation (Kawai et al., 2004) , these results imply that the mechanism of GR-mediated repression operates through both IRF3 and IRF7. These findings thus reveal a mechanism of signal-specific transrepression that is utilized by a large group of functionally interrelated genes. Distinct regions of GR appear to be involved in mediating repression of AP-1 target genes (Bladh et al., 2005) and it will be of interest to explore signal-specific modulation of transrepression in response to other proinflammatory cytokines that induce AP-1 and STAT transcription factors, such as TNFα and IFNβ.
Conversely, the ability of IRF3 to function as an essential coactivator of p65 on a subset of NF-κB target genes provides an explanation for how transrepression by GR can be achieved in a gene-specific manner ( Figure 7D ). NF-κB target genes that are resistant to GR-mediated transrepression are predicted to utilize other classes of coactivators, such as Bcl3 (Leung et al., 2004) , that may prevent the interaction of GR with DNA bound NF-κB. Consistent with this, ChIP experiments demonstrated recruitment of GR to the Dex-sensitive Scyb9 and Clic4 promoters. A significant number of Dex-sensitive NF-κB target genes are not IRF3-dependent, indicating a requirement for additional mechanisms. Virtually all of the Dex-sensitive poly I:C-inducible genes were also Dex sensitive when activated by LPS and CpG1668 (Figure S3A ), suggesting the utilization of common, signal-independent transrepression mechanisms for this class of genes that remain to be defined.
Physiological Implications for Cellular Responses to Bacterial and Viral Pathogens
The observation that TLR-responsive genes exhibit different sensitivities to repression by nuclear receptors suggests that they play distinct biological roles in determining cellular responses to infection and other inflammatory processes. By specifically targeting p65/ IRF3 complexes, GR is able to discriminate signals initiated by TLRs that either do or do not couple to the MyD88 signaling pathway, providing a biological rationale for the context-specific utilization of these complexes. The prediction arising from these studies that 
Clinical Implications
Nuclear receptors are important targets of drugs used in a variety of human disease settings. In many cases, the ability to achieve desirable therapeutic effects with a natural or synthetic nuclear-receptor agonist is limited by undesirable or unacceptable side effects. For example, glucocorticoids are potent anti-inflammatory drugs but can cause or exacerbate hypertension, diabetes, obesity, and dyslipidemia. Emerging information on the ability of selective modulators of nuclear receptors to alter the specificity of coactivator and corepressor recruitment raises new possibilities for the development of novel pharmaceutical agents (Smith and O'Malley, 2004). The present studies suggest an alternative and potentially complementary strategy to leverage desirable therapeutic effects while minimizing side effects. Using chronic, steroid-dependent inflammatory diseases as an example, it is possible that anti-inflammatory actions of synthetic glucocorticoids could be achieved at lower doses with fewer side effects by simultaneous administration of PPARγ or LXR agonists. Further investigation of these combinatorial mechanisms may provide new insights into how nuclear receptors control signal-activated transcription and lead to novel strategies for treatment of inflammatory diseases.
Experimental Procedures
Cell Culture Thioglycollate-elicited macrophages were isolated by peritoneal lavage 3 days following peritoneal injection of 2.5 ml 3% thioglycollate (DIFCO). Cells were plated in RPMI medium 1640 and 10% fetal bovine serum and washed; after 5 hr the medium was removed and cells were fed with fresh medium containing 0.5% fetal bovine serum. LPS (Sigma) was used at a concentration of 100 ng/ml. Nuclear-receptor ligands were used at 1 M concentrations except as indicated. Fetal liver-derived macrophages generated from E14.5 embryo liver were plated and cultured in RPMI with 10% fetal bovine serum plus L cell media for 7 days as described ( 
Expression Array Profiling
Cells were lysed with Trizol (Invitrogen) and total RNA was purified using RNeasy columns (Qiagen). cRNA was generated from 10 g total RNA using Superscript (Invitrogen) and the High Yield RNA transcription labeling kit (Enzo). Fragmented cRNA was hybridized to Affymetrix Mu11 or Codelink mouse Uniset 1 microarrays according to the manufacturer's instructions. Data were analyzed with Microarray Suite (Affymetrix), GeneSpring (Silicongenetics) and inhouse software developed as described (Ogawa et al., 2004) . Two to four biological replicates were performed for each experimental condition. In addition, results for NR transrepression of LPS signaling were independently validated on both microarray platforms.
Computational Analysis
Proximal promoter regions were extracted for each gene represented on the microarray using the May 2004 mouse genome assembly with the method as described (Halees et al., 2003) . Analysis was restricted to the region 1 kb upstream of the transcription start site. In cases were several possible alternative promoters may be present, analysis was focused on the most 5# transcription start site. Motif discovery was performed using a comparative algorithm previously described (Segal et al., 2002) . Promoters were initially divided into two sets: those that were upregulated by LPS and those that were present on the array but did not change in response to LPS. An exhaustive search for all n-mers (6 < n < 12) was performed and each n-mer was scored for its enrichment in the promoters upregulated by LPS using the hypergeometric distribution. The top 500 n-mers with a p value less than 0.01 were then clustered together and used to create position-specific probability matrices. The matrices were then further optimized to discriminate between the LPS responsive and nonresponsive genes by the methods as described (Segal et al., 2002) .
Transient Transfection and Reporter Studies
Transient transfections were performed as described (Ricote et al., 1998) . RAW 264.7 cells were transfected with iNOS promoter luciferase, pCMX-PPARγ and renilla luciferase reporter plasmid was also cotransfected as an internal control (Promega). Cells were treated with LPS in the presence of GR, PPAR, and LXR agonists and harvested 24 hr later for analysis of luciferase activity. Doublestranded, short interfering RNAs (siRNA) were synthesized by Dharmacon Research (Lafayette) and were transfected for 48 hr prior to activation with ligands and LPS induction as previously described . Data are represented as mean ±SD.
GST Pull-Down Assays GST pull-down assays were carried out as described previously (Li et al., 2000) . GST fusion proteins were produced as crude bacterial lysates and immobilized on glutathione agarose beads. p65, IRF3, full-length GR, GR(K471A), and GR-DBD proteins were translated in vitro using 35 S-labeled methionine and TnT-coupled reticulocyte lysate system (Promega). 
ChIP Assay
LPS-Induced Endotoxin Shock and In Vivo Studies
Combinatorial effects of GR, PPARγ, and LXR agonists in antagonism of LPS responses in vivo were evaluated by measuring TNFα and IL-12 p40 levels 6 and 8 hr after intraperitoneal injection of LPS at 1 mg/mouse, respectively. Mice were orally dosed daily with Dex for 7 days and were intraperitoneally injected with LPS (1 mg/ mouse). Blood was collected after LPS stimulation and analyzed for cytokine levels by ELISA. At a minimum, six mice were used for each experimental condition. 
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